| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.006 |